Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

Recruiting now · Not applicable

Conditions studied: Morbid Obesity

In brief

Morbid obesity, is known to be associated with a high risk of VTE and, unfortunately, fixed doses of anticoagulant regimens may not provide optimal VTE prophylaxis in these patients especially after surgery.

Key facts

Study ID

NCT05569681

Run by

Hawler Medical University

People needed

2400

Starts

2023-01-07

Expected to finish

2026-10-02

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants required surgical intervention in: general surgery, gynecology, bariatric surgery
• Moderate, high, and very high risk for venous thromboembolism according to Caprin RAM
• Participant is willing and able to give informed consent for participation in the study.
• BMI ≥40kg/m2

You may not qualify if…

• Having any contraindication to LMWH, such as active bleeding, history of heparin-induced thrombocytopenia , baseline platelet count <75 × 108/μl, severe renal disease (glomerular filtration rate <30 ml/minute), severe liver disease, or uncontrolled hypertension (>200/120 mmHg)
• Known hypersensitivity to unfractionated or LMWHs
• On oral or parenteral anticoagulants within 5 days before surgery
• Severe arterial hypertension
• Unable to comply with the study treatment and/or follow-up
• Receiving prohibited medications
• Pregnancy or lactation mother

Where it is running

• Hawler Medical university — Erbil, Kurdistan Region, Iraq (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.